Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1763.11 Billion JPY | 67.69% |
| 2023 | 1057.05 Billion JPY | 22.22% |
| 2022 | 864.86 Billion JPY | 7.17% |
| 2021 | 807.03 Billion JPY | 1.96% |
| 2020 | 791.54 Billion JPY | -5.58% |
| 2019 | 838.34 Billion JPY | 9.63% |
| 2018 | 764.7 Billion JPY | 2.85% |
| 2017 | 743.54 Billion JPY | 11.56% |
| 2016 | 666.5 Billion JPY | -1.29% |
| 2015 | 675.24 Billion JPY | -20.23% |
| 2014 | 846.51 Billion JPY | 13.4% |
| 2013 | 746.46 Billion JPY | 6.2% |
| 2012 | 702.89 Billion JPY | 18.62% |
| 2011 | 592.53 Billion JPY | -1.24% |
| 2010 | 600 Billion JPY | -0.99% |
| 2009 | 605.98 Billion JPY | 148.99% |
| 2008 | 243.37 Billion JPY | -33.26% |
| 2007 | 364.68 Billion JPY | 5.1% |
| 2006 | 346.98 Billion JPY | 38.68% |
| 2005 | 250.2 Billion JPY | 6.11% |
| 2004 | 235.8 Billion JPY | -5.19% |
| 2003 | 248.7 Billion JPY | 0.0% |
| 2002 | - JPY | 0.0% |
| 2001 | - JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1086.19 Billion JPY | 2.76% |
| 2024 FY | 1763.11 Billion JPY | 66.79% |
| 2024 Q2 | 1055.09 Billion JPY | -2.86% |
| 2024 Q4 | 1763.11 Billion JPY | 4.83% |
| 2024 Q3 | 1681.83 Billion JPY | 59.4% |
| 2023 Q1 | 894.29 Billion JPY | 3.4% |
| 2023 Q3 | 983.7 Billion JPY | 2.4% |
| 2023 FY | 1057.05 Billion JPY | 22.22% |
| 2023 Q4 | 1057.05 Billion JPY | 7.46% |
| 2023 Q2 | 960.62 Billion JPY | 7.42% |
| 2022 Q1 | 782.36 Billion JPY | -3.78% |
| 2022 Q2 | 798.49 Billion JPY | 2.06% |
| 2022 Q3 | 832.24 Billion JPY | 4.23% |
| 2022 FY | 864.86 Billion JPY | 7.17% |
| 2022 Q4 | 864.86 Billion JPY | 3.92% |
| 2021 Q3 | 759.87 Billion JPY | 1.85% |
| 2021 Q2 | 746.03 Billion JPY | -0.14% |
| 2021 Q4 | 813.12 Billion JPY | 7.01% |
| 2021 FY | 807.03 Billion JPY | 1.96% |
| 2021 Q1 | 747.07 Billion JPY | -6.54% |
| 2020 Q3 | 759.46 Billion JPY | -1.42% |
| 2020 Q1 | 806.05 Billion JPY | -3.85% |
| 2020 FY | 791.54 Billion JPY | -5.58% |
| 2020 Q4 | 799.34 Billion JPY | 5.25% |
| 2020 Q2 | 770.43 Billion JPY | -4.42% |
| 2019 Q3 | 658.57 Billion JPY | -0.21% |
| 2019 Q4 | 838.34 Billion JPY | 27.3% |
| 2019 FY | 838.34 Billion JPY | 9.63% |
| 2019 Q1 | 679.81 Billion JPY | -11.1% |
| 2019 Q2 | 659.94 Billion JPY | -2.92% |
| 2018 Q3 | 752.83 Billion JPY | 0.88% |
| 2018 FY | 764.7 Billion JPY | 2.85% |
| 2018 Q2 | 746.29 Billion JPY | -1.05% |
| 2018 Q4 | 764.71 Billion JPY | 1.58% |
| 2018 Q1 | 754.24 Billion JPY | 1.44% |
| 2017 Q3 | 760.51 Billion JPY | 0.03% |
| 2017 Q1 | 655.64 Billion JPY | -1.7% |
| 2017 FY | 743.54 Billion JPY | 11.56% |
| 2017 Q4 | 743.55 Billion JPY | -2.23% |
| 2017 Q2 | 760.32 Billion JPY | 15.97% |
| 2016 Q4 | 667 Billion JPY | 2.15% |
| 2016 Q2 | 630.63 Billion JPY | -2.34% |
| 2016 Q3 | 652.97 Billion JPY | 3.54% |
| 2016 FY | 666.5 Billion JPY | -1.29% |
| 2016 Q1 | 645.77 Billion JPY | -4.36% |
| 2015 Q1 | 755.2 Billion JPY | -10.79% |
| 2015 Q3 | 829.49 Billion JPY | 6.83% |
| 2015 Q4 | 675.24 Billion JPY | -18.6% |
| 2015 FY | 675.24 Billion JPY | -20.23% |
| 2015 Q2 | 776.42 Billion JPY | 2.81% |
| 2014 Q4 | 846.51 Billion JPY | 2.57% |
| 2014 Q3 | 825.3 Billion JPY | 0.8% |
| 2014 Q2 | 818.75 Billion JPY | 10.97% |
| 2014 Q1 | 737.84 Billion JPY | -1.16% |
| 2014 FY | 846.51 Billion JPY | 13.4% |
| 2013 Q4 | 746.46 Billion JPY | 11.16% |
| 2013 FY | 746.46 Billion JPY | 6.2% |
| 2013 Q3 | 671.55 Billion JPY | -0.18% |
| 2013 Q2 | 672.78 Billion JPY | -1.16% |
| 2013 Q1 | 680.7 Billion JPY | -3.16% |
| 2012 FY | 702.89 Billion JPY | 18.62% |
| 2012 Q1 | 589.51 Billion JPY | -0.51% |
| 2012 Q2 | 577.8 Billion JPY | -1.99% |
| 2012 Q3 | 621.47 Billion JPY | 7.56% |
| 2012 Q4 | 702.89 Billion JPY | 13.1% |
| 2011 Q4 | 592.53 Billion JPY | 2.39% |
| 2011 FY | 592.53 Billion JPY | -1.24% |
| 2011 Q1 | 577.98 Billion JPY | -3.67% |
| 2011 Q2 | 572.87 Billion JPY | -0.88% |
| 2011 Q3 | 578.69 Billion JPY | 1.02% |
| 2010 Q3 | 556.49 Billion JPY | -4.07% |
| 2010 FY | 600 Billion JPY | -0.99% |
| 2010 Q2 | 580.09 Billion JPY | 0.0% |
| 2010 Q4 | 600 Billion JPY | 7.82% |
| 2009 FY | 605.98 Billion JPY | 148.99% |
| 2009 Q4 | 605.98 Billion JPY | 0.0% |
| 2008 FY | 243.37 Billion JPY | -33.26% |
| 2007 FY | 364.68 Billion JPY | 5.1% |
| 2006 FY | 346.98 Billion JPY | 38.68% |
| 2005 FY | 250.2 Billion JPY | 6.11% |
| 2004 FY | 235.8 Billion JPY | -5.19% |
| 2003 FY | 248.7 Billion JPY | 0.0% |
| 2002 FY | - JPY | 0.0% |
| 2001 FY | - JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AstraZeneca PLC | 61.86 Billion USD | -2749.915% |
| Bristol-Myers Squibb Company PFD CONV 2 | 65.67 Billion USD | -2584.647% |
| CSPC Pharmaceutical Group Limited | 1.53 Billion USD | -114401.847% |
| Clarus Therapeutics Holdings, Inc. | 67.62 Million USD | -2607016.98% |
| Novartis AG | 53.19 Billion USD | -3214.437% |
| PT Kalbe Farma Tbk. | 255.94 Million USD | -688776.904% |